Head-and-neck paragangliomas are associated with sleep-related complaints, especially in the presence of carotid body tumors by Havekes, Bas et al.
ORIGINAL ARTICLE
Head-and-neck paragangliomas are associated
with sleep-related complaints, especially
in the presence of carotid body tumors
Bas Havekes & Florine Kastelein & Agatha A. van der Klaauw & Nicolette van Duinen &
Jeroen C. Jansen & Jan W. A. Smit & Klaas W. van Kralingen &
Annette H. J. T. Vriends & Johannes A. Romijn & Eleonora P. M. Corssmit
Received: 17 December 2010 /Revised: 10 May 2011 /Accepted: 17 May 2011 /Published online: 27 May 2011
# The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract
Objectives The carotid body functions as a chemoreceptor.
We hypothesized that head-and-neck paragangliomas
(HNP) may disturb the function of these peripheral chemo-
receptors and play a role in sleep-disordered breathing.
Design This is a case–control study.
Setting This study was conducted in a tertiary referral center.
Participants and main outcome measures We assessed
fatigue, sleep, and exercise capacity in 74 HNP patients
using three questionnaires (Epworth Sleepiness Scale,
St. George Respiratory Questionnaire, and a standard
clinical sleep assessment questionnaire). Outcomes were
compared to those of age- and sex-matched controls.
Results and conclusions Activity, disturbance of psychoso-
cial function, and total score were worse compared to
controls (15.4±18.5 vs. 7.2±9.9, P=0.007; 5.3±10.5 vs.
1.2±2.6, P=0.008; and 10.4±12.9 vs. 5.0±4.8, P=0.006,
respectively). Patients reported more daytime fatigue, con-
centration difficulties, and depression (51% vs. 24%, P=
0.006; 31% vs. 10%, P=0.010; and 19% vs. 2%, P=0.012).
W a k i n gu pw a sr e p o r t e dt ob el e s sr e f r e s h i n gi nH N P
patients (53% vs. 73%, P=0.038). Dysphonia was a
predictor of symptoms, activity, disturbance of psycho-
social function, and total scores. Remarkably, the presence of
a carotid body tumor was an independent predictor of
increased daytime sleepiness (β=0.287, P=0.029). In con-
clusion, patients with HNP have remarkable sleep-related
complaints. Especially the presence of carotid body
tumors appears to be associated with increased daytime
somnolence.
Keywords Paraganglioma.Glomus tumors.Carotid body
tumor.Sleep.SDHD mutation
Abbreviations
HNP Head-and-neck paraganglioma
CBT Carotid body tumor
ESS Epworth Sleepiness Scale
SGRQ St. George Respiratory Questionnaire
SCAQ Standard clinical assessment questionnaire
Introduction
Head-and-neckparagangliomas(HNP)arehighly vascularised
tumors originating from neural crest-derived chief cells
of the paraganglia belonging to the autonomic nervous
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DOI 10.1007/s11325-011-0538-5system and are also known as glomus tumors. One of the
paraganglia in the neck is the carotid body which
normally functions as a peripheral chemoreceptor by
registering the arterial oxygen and carbon dioxide (CO2)
concentration [1–7]. HNP are most frequently found in the
carotid body region and this subset of paragangliomas is
called carotid body tumors (CBT). Paragangliomas can
occur in a hereditary context. Familial paraganglioma
syndromes are associated with germline mutations in the
genes encoding the B, C, and D subunits of mitochondrial
complex II succinate dehydrogenase (SDH). These SDH
genes may behave as tumor suppressor genes [8–10].
Among these three genes, mutations in SDH-D subunit are
the most prominent cause of HNP [11–14].
Although these tumors are usually benign, the location
of HNP in close proximity to nerves and vasculature can
result in considerable morbidity. Patients often complain of
progressive dysphagia, dysphonia, and hearing loss. We
recently found that quality of life (QoL) parameters,
assessed by validated questionnaires, are reduced in para-
ganglioma patients [15]. These patients frequently reported
fatigue, reduced exercise tolerance, and impaired sleep.
This disturbed sleep is of interest since the metabolic
ventilatory control system is fine-tuned by two sets of
chemoreceptors, the peripheral chemoreceptors in the
carotid bodies and the central CO2 chemoreceptors in the
ventral medulla. Bilateral dysfunction of carotid body
chemoreceptors causes an abolition of the ventilatory
response to hypoxia under normocapnic conditions [16,
17]. The permanent absence of the breathing response to
hypoxia and the reduction of central CO2 sensitivity after
bilateral carotid body resection may worsen sleep-
disordered breathing [18]. Therefore, the aim of the present
study was to specify sleep-related complaints in para-
ganglioma patients, especially in those with carotid body
tumors, using three questionnaires: Epworth Sleepiness
Scale (ESS), St. George Respiratory Questionnaire
(SGRQ), and a third questionnaire that ensured a standard-
ized clinical assessment of these sleep-related complaints.
Patient outcomes of fatigue, sleep, and exercise capacity
parameters were compared with an age- and sex-adjusted
control group.
Patients and methods
Study protocol
Consecutive patients were recruited from the outpatient
clinic of the department of endocrinology in the Leiden
University Medical Center, which is a tertiary referral
center for HNP. A total of 105 consecutive patients with
HNP were asked to participate in this study. The three
questionnaires were sent to their homes in prepaid envelopes.
Nonresponders were encouraged by phone to complete
and return the questionnaires. Each patient was asked to
provide a control person of comparable sex and age. In
addition, for every patient, one age- and sex-matched
control subject was derived from a database containing
results of similar questionnaires in healthy controls in our
center [19]. The medical ethics committee of the Leiden
University Medical Center approved the study protocol.
Study parameters
Primary study parameters were the results of the three
questionnaires. The results were linked to characteristics
(age and gender) of the patients; the presence of carotid
body tumors, number, size estimate, and location of HNP;
surgical procedures; and clinical data. Tumor size was
estimated by using the product of the two largest diameters
on previous MRI, and patients were subsequently divided
into two groups. As a cutoff value in tumor size estimate,
we used 8 cm
2.
Sleep questionnaires
Epworth Sleepiness Scale
The ESS is a validated self-administered questionnaire
that has been proposed as a method for measuring
daytime sleepiness in adults. The subject is asked to rate
on a scale of 0 to 3 the chances he/she would doze in
each of eight different situations that are commonly met
in daily life (0=would never doze, 3=high chance of dozing).
The ESS score is the sum of the eight items score and can
range from 0 to 24. The normal range of ESS scores is 2–10
with a normal distribution. A score of 10 or more is
considered increased [20, 21].
St. George Respiratory Questionnaire
The SGRQ is a validated self-administered questionnaire
that has been proposed as a method for measuring
health-related quality of life in chronic respiratory
patients. It contains 50 items divided into three sub-
scales: symptoms (8 items), activity (16 items), and
disturbance of psychosocial function (26 items). Each
item in the questionnaire has a weight attached, which
provides an estimate of the distress associated with the
symptom or state described. A score can be calculated
for each subscale of the SGRQ, and also an overall score
can be calculated. SGRQ scores range from 0 to 100, 0
score indicating no impairment of quality of life. A four-point
change in SGRQ is considered a clinically significant
difference [22].
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This questionnaire is frequently used in our hospital as a
tool in clinical practice and research. Studies using this
questionnaire have been published in peer-reviewed
journals [23]. The standard clinical assessment question-
naire (SCAQ) may be used to screen patients for diseases
which cause daytime sleepiness like: obstructive sleep
apnea syndrome, depression, and restless legs syndrome.
The SCAQ contains 12 yes/no items about snoring, loud
and irregular snoring, environmental complaints about
snoring, apnea, history of cardiovascular disease or
hypertension, daytime sleepiness, refreshed when waking
up, daytime fatigue, concentration difficulties, dyspnea or
restless legs at night, and feelings of depression. In
addition, three items on the assessment of bedtime, sleep
onset, and rising time are present. Sleep duration and
midsleep (clock time halfway during sleep duration) are
calculated from sleep onset and rising time.
Statistics
SPSS for Windows version 12.0 (SPSS Inc., Chicago, IL)
was used for data analysis. Data are expressed as
percentages or as mean±SD. We used chi-squared tests,
unpaired T tests to compare patient and control data, and
one-way analysis of variance (ANOVA) to compare several
subgroups of patients, when appropriate. Independent
variables affecting ESS and SGRQ scores were assessed
by using linear regression analysis. These results were
expressed as standardized β of independent predictive
values. P<0.05 was considered significant.
Results
Patients and controls
A total of 76 of 105 patients (72%) returned the question-
naires, 2 of whom preferred not to participate (Table 1). Thus,
74 completed questionnaires were received (70%). The
patient group (53% men) had a mean age of 49±12 years.
No significant differences in age, gender, and number of
paragangliomas were found between the study population
and the patients who did not return or complete the
questionnaires.
Of the paraganglioma patients, 40% had one glomus
tumor, 23% had two glomus tumors, whereas 37% was
diagnosed with three or more tumors. Carotid body tumors
were found in 85% of the patients and more than half of
these patients had been operated at some point during
follow-up. In 40% of HNP patients, one or more carotid
body tumors were apparent without the presence of other
glomus tumors. In our study population, eight of these
patients had bilateral carotid body tumors (11%). Sixty-
one percent was classified as the larger tumor size
estimate group. Intra-adrenal paragangliomas (pheochro-
mocytomas) had previously been identified in 11
patients, whereas 2 patients were diagnosed with an
extra-adrenal paraganglioma.
Complaints of hearing loss and tinnitus were present in
40% and 34% of the patients, respectively. Dysphonia was
present in 18% the patients, and dysphagia was reported by
25% of the patients. Genetic analysis had been performed
in 51 of 74 patients (69%). In 49 of these patients, an
SDHD mutation was found (96%).
The 76 patients who returned the questionnaires provided
41 controls (54%). The control group (46% men) had a
mean age of 45±11 years. There were no significant
differences in mean age and sex between patients and
controls. For every patient one age- and sex-matched
control subject was found in the database to create the
larger control group (Leiden controls). The Leiden
control group (53% men) had a mean age of 52±9 years.
Sleep-related complaints in patients with HNP
Epworth Sleepiness Scale
No significant difference in daytime sleepiness was present
between the group of HNP patients as a whole and the
control group on the Epworth Sleepiness Scale (Table 2).
St. George Respiratory Questionnaire
The scores on three of the four subscales of the SGRQ were
significantly increased in HNP patients. Activity, distur-
bance of psychosocial function, and total score were worse
in patients compared to own controls (15.4±18.5 vs. 7.2±
9.9, P=0.007; 5.3±10.5 vs. 1.2±2.6, P=0.008; and 10.4±
12.9 vs. 5.0±4.8, P=0.006). No difference was found in
symptom scores. For this questionnaire we did not have an
extended control group to include in our analyses, therefore
these data are missing in Table 2.
Standard clinical assessment questionnaire
On the standard sleep questionnaire, patients reported more
daytime fatigue, concentration difficulties, and symptoms
of depression (51% vs. 24%, P=0.006; 31% vs. 10%, P=
0.010; and 19% vs. 2%, P=0.012, respectively). They also
woke up less refreshed compared to both own controls and
the extended control group (53% vs. 73%, P=0.038 and
53% vs. 74%, P=0.010, respectively). Dyspnea, restless
legs, and history of cardiovascular disease or hypertension
were increased as compared to the own control group (14%
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(n=74)
Controls
(n=41)
Leiden controls
(n=74)
Age (years) 49.1±12.2 45.0±11.4 52.2±8.9
Sex (male/female) 39/35 18/23 39/35
Height (m) Male 1.79±0.06
Female 1.67±0.08
Weight (kg) Male 83±14
Female 67±12
Body mass index Male 26±4
Female 24±5
1 glomus tumor 29 (40%)
2 glomus tumors 17 (23%)
≥3 glomus tumors 27 (37%)
CBT without other GT 29 (40%)
Bilateral CBT without other GT 8 (11%)
Hearing loss 26 (40%)
Tinnitus 22 (34%)
Dysphonia 12 (18%)
Dysphagia 16 (25%)
Patients tested for mutation 51 (69%)
SDH-D subunit (D92Y) mutation 49 (66%)
Table 1 Characteristics of
head-and-neck paraganglioma
patients and controls
Paraganglioma
(n=74)
Controls
(n=41)
P value Leiden controls
(n=74)
P value
ESS
Total score 6.1±4.1 5.7±3.9 0.555 5.1±3.5 0.092
Total score ≥10 21% 20% 0.867 12% 0.158
SGRQ
Symptoms score 17.1±19.3 12.2±13.5 0.128
Activity score 15.4±18.5 7.2±9.9 0.007*
Disturbance of psychosocial function 5.3±10.5 1.2±2.6 0.008*
Total score 10.4±12.9 5.0±4.8 0.006*
SCAQ
Snoring 66% 54% 0.203 68% 0.816
Loud and irregular snoring 37% 35% 0.865 33% 0.637
Complaints of environment 30% 30% 0.988 29% 0.881
Apnea 16% 10% 0.423 8% 0.176
Cardiovascular disease or hypertension 45% 24% 0.032* 37% 0.348
Daytime sleepiness 39% 25% 0.137 27% 0.127
Waking up refreshed 53% 73% 0.038* 74% 0.010*
Daytime fatigue 51% 24% 0.006* 28% 0.006*
Concentration difficulties 31% 10% 0.010* 7% 0.000*
Waking up at night by dyspnea 14% 0% 0.014* 5% 0.092
Restless legs 34% 12% 0.012* 22% 0.098
Feeling depressed 19% 2% 0.012* 4% 0.005*
Sleep onset 23:28±0:50 23:21±0:54 0.531 23:35±0:58 0.390
Sleep duration 7:18±1:06 7:14±0:58 0.764 7:24±0:58 0.517
Midsleep 3:06±0:42 2:58±0:38 0.317 3:18±0:44 0.116
Rising time 6:44±0:56 6:35±0:41 0.410 7:00±0:48 0.058
Table 2 Results of question-
naires in head-and-neck
paraganglioma patients
ESS Epworth Sleepiness Scale,
SGRQ St. George Respiratory
Questionnaire, no Leiden con-
trols available for SGRQ, SCAQ
standard clinical assessment
questionnaire
*P<0.05
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24%, P=0.032, respectively). However, in comparison to
the Leiden control group, no differences were found. The
percentage of patients with snoring, apnea, and daytime
sleepiness was not significantly different in HNP patients
compared to controls. Sleep onset, sleep duration, midsleep,
and rising time were also reported equally.
Factors influencing daytime sleepiness in patients with HNP
Age
No significant correlations were found between age and ESS
scores or between age and SGRQ scores. Age did increase
complaints of dyspnea at night (β=0.572, P=0.024).
Gender
There were no significant correlations between gender and
ESS scores or between gender and SGRQ scores. Women
reported significantly more complaints of daytime fatigue
and restless legs at night in the clinical assessment
questionnaire (65% vs. 38%, P=0.025 and 46% vs. 23%,
P=0.040, respectively). Men reported sleep apnea more
often (29% vs. 0%, P=0.001).
Dysphonia
Dysphonia was present in 18% of the patients. Dysphonia
could not be related to a change in ESS scores. However, on
the SGRQ, patients with dysphonia had worse symptoms,
disturbance of psychosocial function, and total scores (31.8±
22.9 vs. 12.7±16.6, P=0.002; 12.8±17.7 vs. 3.9±8.6, P=
0.029; and 21.2±21.7 vs. 8.4±10.3, P=0.010, respectively).
Number and estimated size of paragangliomas
Sixty percent of patients had multiple HNP. In addition to
snoring and loud or irregular snoring on the standard
clinical questionnaire (77% vs. 52%, P=0.027 and 47% vs.
22%, P=0.041), no other differences were present. The
group with larger tumors tended to have more apnea (24%
vs. 0%, P=0.07) and a higher disturbance of psychosocial
function (11.8±16.9 vs. 2.5±5.6, P=0.05). However, the
group with the smaller estimates of tumor size reported
more daytime sleepiness and fatigue (29% vs. 71%, P=0.01
and 41% vs. 79%, P=0.03).
Carotid body tumors
Patients with a carotid body tumor reported more com-
plaints of daytime sleepiness on the ESS compared to
patients without carotid body tumors (6.6±4.2 vs. 2.6±2.0,
P=0.028; Table 3). There were no differences when
comparing patients with a single carotid body tumor,
bilateral carotid body tumors, or multiple tumors
including a carotid body tumor. The percentage of
patients with an ESS score of 10 or more tended to
be increased in paraganglioma patients with bilateral
carotid body tumors compared to HNP patients without
a carotid body tumor (26.9% vs. 0%, P=0.068). In the
clinical assessment questionnaires, patients with bilateral
carotid body tumors reported more complaints of snoring
(82% vs. 40%, P=0.012).
Recent catecholamine excess
In total, 14 patients had had at least one catecholamine-
positive urine sample in the preceding year. No significant
differences between patients with and without catecholamine
excess were found in this study.
Surgery
Results in patients with a single CBT are shown in Table 4.
Surgical removal of a single CBT was not associated with a
different outcome in this study.
Linear regression analysis (multivariate analysis)
Stepwiselinearregressionwasperformedinamodelincluding
age, gender, dysphonia, difficulties with swallowing,
number of HNP, and the presence of carotid body tumors
as independent variables and ESS scores and SGRQ
scores as dependent variables. Age was an independent
p r e d i c t o ro fm i d s l e e p( β=0.389, P=0.005). Gender was
not an independent predictor in this analysis. Dysphonia
was found to be an independent predictor of symptoms,
activity, disturbance of psychosocial function, and total
scoresoftheSGRQ(β=0.434,P=0.001;β=0.325,P=0.043;
β=0.390, P=0.015; and β=0.434, P=0.007, respectively).
The presence of a carotid body tumor was an indepen-
dent predictor of daytime sleepiness (β=0.287, P=0.029)
according to the ESS questionnaire. Surgery was not
found as an independent predictor.
Discussion
Synopsis of key findings
In this study we investigated daytime sleepiness, common
sleep-related complaints, and exercise capacity in patients
with HNP using questionnaires. Daytime fatigue, concen-
tration difficulties, waking up less refreshed, and feelings of
depression were found more often in HNP patients.
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in patients with one or more carotid body tumors,
compared to patients without a carotid body tumor.
Clinicians need to be aware that carotid bodies may
have a distinct role in sleep-related complaints in these
patients. However, based on the data of our study, we
cannot exclude mechanical airway obstruction to have
bearing on our results. Further detailed polysomno-
graphic and ventilatory studies with arterial blood gas
analyses in both pre- and postoperative patients would be
helpful to further elucidate the pathophysiology.
Comparisons with other studies
Although several studies have investigated clinical presen-
tations of HNP patients, data regarding sleep in these
patients are limited. Recently, we performed a QoL study
in HNP patients using validated general health-related
questionnaires that reported an increase of fatigue and
sleep disorders in these patients [15]. Therefore, in the
present study, we included questionnaires that were more
specifically designed to assess sleep-related complaints.
Daytime fatigue, concentration difficulties, being less
r e f r e s h e do nw a k i n gu p ,a n df e e l i n g so fd e p r e s s i o nw e r e
reported to be worse in patients as compared to controls,
thus suggesting an association of HNP and/or its treatment
with sleep-related disorders. Dysphonia was found to be
an independent predictor of symptoms, disturbance of
psychosocial function, and total scores according to the
SGRQ, which is concordant with our results in the QoL
study.
In HNP patients with one or more carotid body tumors,
total scores on daytime sleepiness were significantly higher
compared to patients without carotid body tumors. How-
ever, using the ESS score of 10 or higher as a cutoff value,
a significant difference was only found in patients with
bilateral carotid body tumors. In the literature, case reports
have been published suggesting associations between
carotid body tumors and sleep apnea or hypoventilation
[2, 24–27]. Reports have been published describing
obstructive sleep apnea syndrome caused by the presence
of carotid body tumors with (partial) relief after surgical
removal [24, 26]. On the other hand, the development of an
abnormal hypoxic ventilatory drive and hypoventilation
syndromes after the surgical removal of (bilateral) carotid
body tumors has been reported as well [2, 27, 28]. In our
study, no significant results concerning the effects of
surgery could be found; however, this might be due to the
small number of patients that had been operated in our
cohort. The percentage of paraganglioma patients in the
present study that reported sleep apnea was not significantly
increased in comparison with controls. However, in the
present study, apnea was only assessed by using self-
reported questionnaires and many patients and controls
did not know whether or not they had sleep apnea. In
addition, although we did not have the exact tumor
volumes, our data suggest that sleep apnea may be more
Table 3 Daytime sleepiness in patients with CBT compared to patients without CBT using ANOVA analysis
No CBT
a (n=10) Single CBT
a (n=35) P value Bilateral CBT
a (n=26) P value CBT
b (n=61) P value
ESS
Total score 2.6±2.0 6.6±4.2 0.018* 6.7±4.0 0.019* 6.6±4.1 0.028*
Total ≥10 0% 20% 0.124 26.9% 0.068 23% 0.091
SCAQ
Snoring 40% 62% 0.222 82% 0.012* 71% 0.054
Apnea 10% 10% 1 22.7% 0.39 15% 0.658
CBT carotid body tumor, ESS Epworth Sleepiness Scale, SCAQ standard clinical assessment questionnaire
*P<0.05
aOther paraganglioma than CBT possibly present
bCBT present (single and multiple combined) compared to “No CBT”
Table 4 Daytime sleepiness and sleep disorders in patients with
surgical removal of a carotid body tumor
Single CBT without
surgery (n=10)
Single CBT with
surgery (n=11)
P value
ESS
Total score 5.8±4.7 7.7±4.6 0.353
Total score ≥10 20% 27% 0.696
SCAQ
Snoring 70% 45% 0.256
Apnea 22% 11% 0.466
Restless legs 30% 27% 0.890
ESS Epworth Sleepiness Scale, SCAQ standard clinical assessment
questionnaire
*P<0.05
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tumors. Considering these observations and the increased
daytime sleepiness in patients with carotid body tumors,
the results of our study warrant additional sleep apnea
studies, like polysomnography, in addition to these self-
reported questionnaires.
We did not find a correlation between age and sleepiness
by univariate analysis, which is in contrast with findings in
the general healthy population [29, 30]. This discrepancy
could be due to the limited age range of the subjects
included in our study. In the multivariate regression
analysis, age was an independent predictor of midsleep. In
this study patients were compared with own controls and
controls derived from previous studies performed in this
hospital. The advantage of using own controls is that they
are from the same geographic area and socioeconomic class
as the patients [31]. However, there may be a selection
bias, because patients could have chosen subjects with a
good health status [32]. In addition, a considerable number
of control subjects chose to return the questionnaires
unanswered, resulting in a relatively small number of own
controls. Therefore, for every patient, one age- and sex-
matched control subject was derived from a database
containing results of similar questionnaires, except for the
SGRQ results, in healthy controls in our center.
Respiratory drive during non-rapid eye movement sleep
is mainly influenced by the metabolic (autonomic) control
system, and therefore chemoreceptors alone may be
responsible for providing effective input to the respiratory
center in the brain stem [1, 3, 4, 6, 7, 18, 33]. The carotid
body is the most powerful peripheral chemoreceptor
sensitive mainly to arterial oxygen tension. In response to
hypoxia, the firing rate of chemosensory impulses increases
in the carotid sinus nerve. The impulses reach the
respiratory center in the brain stem via the glossopharyng-
eal nerve, resulting in an increase in ventilation. In HNP
patients the function of these peripheral chemoreceptors
may be disturbed, either in the carotid body tumor itself or
adjacent nerves. Ventilatory responses to hypoxia may be
less adequate [4, 16, 24, 28, 33, 34]. Our results suggest
that patients with carotid body tumors have more
complaints of daytime sleepiness than patients without
carotid body tumors. Thus, we could hypothesize that
disturbed chemoreceptor function in HNP patients might
be contributory to increased daytime sleepiness, especially in
those with carotid body tumors.
Clinical applicability of the study
Of course the hypothesis that dysfunction and/or removal of
these carotid bodies (that play a role in controlling
breathing) are directly responsible for the impaired sleep
is appealing. However, since we did not specifically
investigate airway resistance in our study, we were not
able to estimate the contribution of a purely mechanical
obstruction of the upper airways to the reported complaints.
The dilator muscles of the upper airway have been shown
to play a critical role in maintaining patency of the
oropharynx during inspiration [35]. Obstructive sleep apnea
has been shown to occur in patients with inadequate
activity of the glenioglossus, the main protrusor muscle of
the tongue [36]. Neural output to the glenioglossus is
stimulated largely by input from the peripheral chemo-
receptors [37, 38]. This might be of critical importance to
the control of the airway resistance in patients who have
undergone surgical removal of carotid bodies. Importantly,
larger paragangliomas in situ may also cause direct
compression of the upper airway. Interestingly, albeit not
significantly, sleep apnea tended to be more frequent in the
group with the larger tumors. Unfortunately, we could not
precisely calculate tumor volume and did not perform
additional studies. This remains to be further analyzed in
future studies.
In conclusion, we found self-reported, sleep-related
problems to be increased in HNP patients. Remarkably,
patients with carotid body tumors had increased daytime
sleepiness compared to patients without carotid body
tumors. Clinicians need to be aware that carotid bodies
may have a distinct role in sleep-related complaints in these
patients. However, based on the data of our study, we
cannot exclude mechanical airway obstruction to have
bearing on our results. Further detailed polysomnographic
and ventilatory studies with arterial blood gas analyses in
both pre- and postoperative patients would be helpful to
further elucidate the pathophysiology.
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